Citation 5579

JANG,DS: LEE,GY: LEE,YM: KIM,YS: SUN,H: KIM,DH: KIM,HS:. (2009). FLAVAN-3-OLS HAVING A GAMMA -LACTAM FROM THE ROOTS OF ACTINIDIA ARGUTA INHIBIT THE FORMATION OF ADVANCED GLYCATION END PRODUCTS IN VITRO. 57(4)

Citation Details

Title	FLAVAN-3-OLS HAVING A GAMMA -LACTAM FROM THE ROOTS OF ACTINIDIA ARGUTA INHIBIT THE FORMATION OF ADVANCED GLYCATION END PRODUCTS IN VITRO
Authors	JANG,DS: LEE,GY: LEE,YM: KIM,YS: SUN,H: KIM,DH: KIM,HS:
Year	2009
Volume	57
Issue	4

Summary

Year: 2009

Journal: Unknown

Organisms and Their Experiments (1)

Actinidia arguta (ACTINIDIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CATECHIN,(-)-EPI:6-(2-PYRROLIDINONE-5-YL):	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CATECHIN,(-)-EPI:8-(2-PYRROLIDINONE-5-YL):	None
3	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CATECHIN,(-)-EPI:	None
4	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CATECHIN,(+):	None
5	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PROANTHOCYANIDIN B-4	None
6	PROTEIN GLYCATION (ADVANCED GLYCATION ENDPRODUCTS) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(-)-EPI:6-(2-PYRROLIDINONE-5-YL):	ACTIVE
7	PROTEIN GLYCATION (ADVANCED GLYCATION ENDPRODUCTS) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(-)-EPI:8-(2-PYRROLIDINONE-5-YL):	ACTIVE
8	PROTEIN GLYCATION (ADVANCED GLYCATION ENDPRODUCTS) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(-)-EPI:	ACTIVE
9	PROTEIN GLYCATION (ADVANCED GLYCATION ENDPRODUCTS) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
10	PROTEIN GLYCATION (ADVANCED GLYCATION ENDPRODUCTS) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROANTHOCYANIDIN B-4	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED	PINORESINOL	None

Show SPARQL Queries (1)